Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Antiviral Drugs Market
The antiviral drugs market is projected to grow from USD 65,107 million in 2024 to USD 108,519 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.70%.
-
Pharmacogenomics Market
The global demand for pharmacogenomics products was valued at USD 3481.20 million in 2023 and is expected to reach USD 9272.63 million in 2032, growing at a CAGR of 11.50% between 2024 and 2032.
-
Nosocomial Infection Treatment Market
The global demand for nosocomial infection treatment was valued at USD 30154.56 Million in 2023 and is expected to reach USD 35720.76 Million in 2032, growing at a CAGR of 1.90% between 2024 and 2032.
-
Anti-Cancer Drugs Market
The global anti-cancer drugs market is poised for substantial growth, with projections indicating a rise to USD 411.78 billion by 2032, marking a significant increase from its 2023 valuation of USD 198.96 billion.
-
Congenital Disabilities Market
The Global Congenital Disabilities Market is projected to grow from USD 232.19 million in 2023 to USD 345.06 million by 2032, at a compound annual growth rate (CAGR) of 4.50%.
-
Acquired Hemophilia Treatment Market
The Acquired Hemophilia Treatment Market attained a valuation of USD 16581.2 Million in 2023 and is anticipated to escalate to USD 29974.9 Million by 2032, exhibiting a robust CAGR of 6.80% during the forecast period from 2024 to 2032.
-
Tyrosine Kinase Inhibitors (TKIs) Market
The Tyrosine Kinase Inhibitors (TKIs) Market is projected to increase from USD 64,720.8 million in 2024 to USD 109,550.38 million by 2032, representing at a CAGR of 6.80%.
-
Peptide Therapeutics Market
the market for peptide therapeutics is projected to rise at a compound annual growth rate (CAGR) of 7.80%, from an estimated USD 49781.9 million in 2023 to USD 97867.91 million in 2032.
-
Thioredoxin Market
The Thioredoxin Market is projected to witness substantial growth, with its value expected to surge from USD 33,352.36 million in 2023 to USD 58,389.86 million by 2032, reflecting a notable compound annual growth rate of 6.36%.
-
Small Animal Respiratory Diseases Treatment Market
The global demand for small animal respiratory diseases treatment was valued at USD 26.90 Million in 2023 and is expected to reach USD 36.34 Million in 2032, growing at a CAGR of 3.40% between 2024 and 2032.
